3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Breast Neoplasms
22
Neoplasm Metastasis
17
Lung Neoplasms
10
Carcinoma, Hepatocellular
10
Prostatic Neoplasms
9
Melanoma
9
Carcinoma, Renal Cell
9
Carcinoma, Non-Small-Cell Lung
9
Liver Neoplasms
8
Sarcoma
7
Kidney Neoplasms
7
Pain
6
Colorectal Neoplasms
5
Esophageal Neoplasms
4
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Small Cell Lung Carcinoma
3
Osteosarcoma
3
Neoplasms
3
Keratosis, Actinic
3
Cholangiocarcinoma
3
Carcinoma, Ductal, Breast
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Tongue Neoplasms
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Desmoid Tumors
2
Colonic Neoplasms
2
Carcinoma, Transitional Cell
2
Interventions
pembrolizumab
7
Radiotherapy
3
Proton Therapy
3
Interleukin-2
3
Cyclophosphamide
3
spartalizumab
2
fludarabine
2
Rosuvastatin Calcium
2
Paclitaxel
2
Ipilimumab
2
Immune Checkpoint Inhibitors
2
Cetuximab
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
tislelizumab
1
sotorasib
1
peposertib
1
pazopanib
1
patritumab deruxtecan
1
palbociclib
1
osimertinib
1
niraparib
1
neotil
1
necitumumab
1
mirdametinib
1
leronlimab
1
lenvatinib
1
atezolizumab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Solid Tumor, Adult
×
Cryosurgery
×
Clear all
NCT06032845
2025-02-27
CASTLE-11
Fudan University
Phase 2
Recruiting
25 enrolled